FreeMind sees improving federal funding outlook for US life-sciences industry
XLV•FreeMind expects stable or higher NIH funding in 2027. The House Appropriations Committee recommended about $48.8 billion for NIH, compared with $48.7 billion enacted for FY2026; the recommendation is not law.
1. Funding outlook
FreeMind expects stable or higher NIH funding in 2027 and says Democratic control of Congress improves the outlook for life-sciences investment. Greater funding predictability could support hiring, development spending and private investment, though grant competition is expected to remain intense and agency priorities will determine allocations.
2. Budget timing
A temporary funding extension beyond December 11 is considered the most likely outcome, though a full-year FY2027 agreement is possible in December. Broader federal non-dilutive funding opportunities could improve.
